Agios Pharmaceuticals AGIO Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNet.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agios Pharmaceuticals's accounts receivable?
- Agios Pharmaceuticals (AGIO) reported accounts receivable of $16.13M in Q1 2026.
- How has Agios Pharmaceuticals's accounts receivable changed year-over-year?
- Agios Pharmaceuticals's accounts receivable increased by 382.4% year-over-year, from $3.34M to $16.13M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.